Portfolio company
Ocuphire Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops and commercialises therapies for retinal and refractive eye disorders to treat patients with vision impairments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Iveric Bio
This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.
Oculis
This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.
Clearside Biomedical
This biopharmaceutical company develops and commercialises suprachoroidal microinjection devices and therapies for clinicians to treat patients with sight-threatening back-of-the-eye diseases.
EyeBio
This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.
VISUfarma
This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.
oculex-pharmaceuticals
This company develops biodegradable intraocular implants and drug delivery systems to treat retinal diseases for patients with conditions such as macular oedema.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
ONL Therapeutics
This biopharmaceutical company develops neuroprotective peptide therapies to prevent retinal cell death and preserve vision for patients with retinal diseases and conditions.
